Ireland
--:--IST
Active, not recruiting Observational

Retrospective Acute Care Appendectomy Study

NCT06624215 · tracked via the Priya Life Science USA tracker
Phase
Observational
Started
2024-11-22
Last updated
2026-09-24

Condition(s) studied

Acute Appendicitis

Investigational drug(s) / intervention(s)

Appendectomy

Appendectomy: Robotic-assisted or laparoscopic appendectomy for acute appendicitis.

Study summary

The purpose of this retrospective study is to compare perioperative data for subjects who have undergone an emergent or urgent robotic-assisted or laparoscopic appendectomy for acute appendicitis.

Eligibility

Sex
ALL
Min age
22 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Subject is 22 years of age or older at time of procedure * Subject has undergone robotic-assisted or laparoscopic emergent or urgent appendectomy for acute appendicitis between 2018 and 30 days prior to IRB approval Exclusion Criteria: * Subject with appendiceal neoplasms * Subject who underwent a single-port appendectomy * Subject who was pregnant or breastfeeding at the time of the procedure

Primary outcome measure(s)

  • Operative time — Intraoperative
  • Procedure time — Intraoperative
  • Conversion — Intraoperative
  • Adverse events — Intraoperative and postoperative out to 30 days from procedure date
  • Mortality rate through 30 days — Intraoperative and postoperative out to 30 days from procedure date
    All cause
  • Unplanned procedure-related readmission rate through 30 days — Discharge through 30 days
  • Concomitant procedures — Intraoperative
  • Estimated blood loss — Intraoperative
  • Severity of appendicitis — Preoperative
  • Unplanned procedure-related reoperation rate through 30 days — Postoperative through 30 days
  • Length of stay — Start of procedure to discharge from the hospital (check-out time), up to approximately one week
    Total number of days the subject stayed in the hospital after the index procedure prior to being discharged.
  • Discharge disposition — Discharge from the hospital (check-out time), up to approximately one week.
    Where the subject was discharged to when released from the hospital
  • Blood Transfusion — Intraoperative and discharge from the hospital (check-out time), up to approximately one week.
    Any occurrence of blood transfusion either at the time of the procedure or at any point during the post-procedure hospitalization until the participant is discharged.

Trial sites (3)

FacilityCityRegionStatus
The Ohio State University Columbus Ohio
Legacy Emanuel Hospital & Health Center Portland Oregon
Christus Santa Rosa Health Care Corporation New Braunfels Texas
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06624215 on ClinicalTrials.gov ↗ ← All trials in the USA